Johannes G. KHINAST

The digitalisation of Europe is advancing at enormous speed – and this is offering pharmaceutical companies the chance to communicate directly and frequently with individual patients for the first time. The development of intelligent medical products is helping to increase the quality of life and the life expectancy of patients, significantly and for the long term.

AUTHOR

Johannes Khinast
Head of the Institute for Process and Particle Engi­neering at the Graz University of Technology and Scientific Director of the Research Centre for Pharmaceutical Engineering. Several important awards, Marie Curie Chair of the EU in 2005. Significant work on process simulation, pharma­ceutical process engineering and particle techno­logy.

You may also like

Charlotte Stix

Charlotte STIX #01

The concept of Europe entails addressing and preserving fundamental rights and values. These should also influence the digitalisation of our world and […]

Wolfgang Rehner

Wolfgang REHNER

BlessU2 was first introduced in 2017 at the World Exhibition in Wittenberg to celebrate the 500th anniversary of the Reformation, as the […]

Leopold Neuhold

Leopold NEUHOLD #01

Digitalisation is associated with indirectness. What implications does this indirectness have for decision-making?

Sabine Köszegi

Sabine KÖSZEGI

AI systems have the potential to bring fundamental change to our lives in many ways. Only the responsible development, implementation and use […]